These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens. Cornaglia G; Rossolini GM Clin Microbiol Infect; 2009 Mar; 15(3):218-23. PubMed ID: 19335369 [TBL] [Abstract][Full Text] [Related]
5. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections. Chien JW; Kucia ML; Salata RA Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of fluoroquinolones against gram-positive bacteria. Bush K; Goldschmidt R Curr Opin Investig Drugs; 2000 Sep; 1(1):22-30. PubMed ID: 11249591 [TBL] [Abstract][Full Text] [Related]
8. [Therapy of resistant gram-positive infection: value of glycopeptide antibiotics vancomycin and teicoplanin]. Waldvogel F Schweiz Med Wochenschr; 1993 Dec; 123(50):2353-6. PubMed ID: 8272810 [No Abstract] [Full Text] [Related]
10. [Gram-positive bacterial infections resistant to antibiotic treatment]. Utili R Ann Ital Med Int; 2001; 16(4):205-19. PubMed ID: 11799629 [TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria. Rybak MJ Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721 [TBL] [Abstract][Full Text] [Related]
12. Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens. Hirokawa Y; Kinoshita H; Tanaka T; Nakata K; Kitadai N; Fujimoto K; Kashimoto S; Kojima T; Kato S J Med Chem; 2008 Apr; 51(7):1991-4. PubMed ID: 18330977 [TBL] [Abstract][Full Text] [Related]
13. Emerging problems in gram-positive infections in the postoperative patient. Barie PS Surg Gynecol Obstet; 1993; 177 Suppl():55-64; discussion 65-70. PubMed ID: 8256192 [TBL] [Abstract][Full Text] [Related]
14. Review: dalbavancin--a novel lipoglycopeptide antimicrobial for gram positive pathogens. Das B; Sarkar C; Biswas R; Pandey S Pak J Pharm Sci; 2008 Jan; 21(1):78-87. PubMed ID: 18166524 [TBL] [Abstract][Full Text] [Related]
16. The postantibiotic effect (PAE) of the new penem FCE 22101 on gram-positive and -negative bacteria in vitro and in vivo. Bergholm AM; Dornbusch K J Chemother; 1989 Jul; 1(4 Suppl):64-6. PubMed ID: 16312306 [No Abstract] [Full Text] [Related]
17. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Sader HS; Jones RN; Dowzicky MJ; Fritsche TR Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565 [TBL] [Abstract][Full Text] [Related]
18. Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing. Hecht DW Anaerobe; 2006 Jun; 12(3):115-21. PubMed ID: 16765857 [No Abstract] [Full Text] [Related]
19. Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis. Cholongitas E; Papatheodoridis GV; Lahanas A; Xanthaki A; Kontou-Kastellanou C; Archimandritis AJ Liver Int; 2005 Feb; 25(1):57-61. PubMed ID: 15698399 [TBL] [Abstract][Full Text] [Related]
20. The status of antimicrobial resistance in Taiwan among Gram-positive pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme, 2000. McDonald LC; Lauderdale TL; Shiau YR; Chen PC; Lai JF; Wang HY; Ho M; Int J Antimicrob Agents; 2004 Apr; 23(4):362-70. PubMed ID: 15081085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]